1. Home
  2. CCS vs IMNM Comparison

CCS vs IMNM Comparison

Compare CCS & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$60.30

Market Cap

1.9B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.42

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
IMNM
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
CCS
IMNM
Price
$60.30
$19.42
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$70.50
$26.89
AVG Volume (30 Days)
240.3K
1.2M
Earning Date
01-28-2026
11-06-2025
Dividend Yield
1.92%
N/A
EPS Growth
N/A
N/A
EPS
6.93
N/A
Revenue
$4,157,669,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.74
N/A
P/E Ratio
$8.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.42
$5.15
52 Week High
$88.41
$20.46

Technical Indicators

Market Signals
Indicator
CCS
IMNM
Relative Strength Index (RSI) 45.91 60.95
Support Level $63.69 $16.81
Resistance Level $67.10 $20.46
Average True Range (ATR) 2.10 1.20
MACD -0.03 0.03
Stochastic Oscillator 38.97 72.74

Price Performance

Historical Comparison
CCS
IMNM

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: